Clinical Trials

Enrollment in one of our clinical trials is our primary method for providing patients with access to our investigational drugs prior to their potential approval by regulatory authorities, including the United States Food and Drug Administration, and subsequent commercial availability. Clinical trials are required to demonstrate that an investigational drug meets safety and efficacy standards necessary for approval by regulatory authorities.

We conduct our clinical trials to the highest possible standards and in accordance with our ethical, legal and regulatory obligations. The safety of patients is always our priority.

Patient Resources

We are passionate about improving health and committed to helping people with cancer.

Patients and families should speak to their physician about risks and benefits of a clinical trial and to ask whether a study is right for them. For more information about participating in clinical trials, click on the resources below:

• CTIM-76 (CLDN6 x CD3): A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors